Compare TEVA & TS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEVA | TS |
|---|---|---|
| Founded | 1901 | 2001 |
| Country | Israel | Luxembourg |
| Employees | 32842 | 24875 |
| Industry | Biotechnology: Pharmaceutical Preparations | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.5B | 32.0B |
| IPO Year | N/A | N/A |
| Metric | TEVA | TS |
|---|---|---|
| Price | $36.35 | $62.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 5 |
| Target Price | $38.63 | ★ $58.80 |
| AVG Volume (30 Days) | ★ 5.6M | 1.8M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.80% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1.53 |
| Revenue Next Year | $2.97 | $3.59 |
| P/E Ratio | $28.19 | ★ $12.59 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.99 | $32.00 |
| 52 Week High | $37.35 | $64.33 |
| Indicator | TEVA | TS |
|---|---|---|
| Relative Strength Index (RSI) | 74.07 | 59.86 |
| Support Level | $30.53 | $56.88 |
| Resistance Level | $37.35 | N/A |
| Average True Range (ATR) | 1.00 | 1.00 |
| MACD | 0.51 | -0.13 |
| Stochastic Oscillator | 97.85 | 75.32 |
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Tenaris SA is engaged in the manufacture and supply of steel pipe products and related services for the energy industry and other industrial applications. The company has one reportable segment, Tubes, which includes the production and sale of steel tubular products such as OCTG, line pipe, and mechanical and structural tubes, mainly for the oil and gas industry. It operates an integrated network of manufacturing, research, and service facilities across the Americas, Europe, the Middle East, Asia, and Africa.